Patient, Consumer, and Public Health Coalition Comments on FDA Draft Guidance on Pharmacy Compounding of Human Drug Products

February 6, 2014. As members of the Patient, Consumer, and Public Health Coalition, we conditionally support the draft guidance “Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal Food, Drug, and Cosmetic Act” (FD&C) because it clarifies FDA enforcement actions that can be taken against individuals or firms that illegally make drugs under the banner of traditional compounding.

Read More »